1. Home
  2. RGNX vs NFGC Comparison

RGNX vs NFGC Comparison

Compare RGNX & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • NFGC
  • Stock Information
  • Founded
  • RGNX 2008
  • NFGC 2016
  • Country
  • RGNX United States
  • NFGC Canada
  • Employees
  • RGNX N/A
  • NFGC N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • NFGC Precious Metals
  • Sector
  • RGNX Health Care
  • NFGC Basic Materials
  • Exchange
  • RGNX Nasdaq
  • NFGC Nasdaq
  • Market Cap
  • RGNX 459.1M
  • NFGC 434.8M
  • IPO Year
  • RGNX 2015
  • NFGC N/A
  • Fundamental
  • Price
  • RGNX $9.18
  • NFGC $1.62
  • Analyst Decision
  • RGNX Strong Buy
  • NFGC Strong Buy
  • Analyst Count
  • RGNX 12
  • NFGC 1
  • Target Price
  • RGNX $36.36
  • NFGC $9.00
  • AVG Volume (30 Days)
  • RGNX 886.8K
  • NFGC 629.8K
  • Earning Date
  • RGNX 11-06-2024
  • NFGC 11-12-2024
  • Dividend Yield
  • RGNX N/A
  • NFGC N/A
  • EPS Growth
  • RGNX N/A
  • NFGC N/A
  • EPS
  • RGNX N/A
  • NFGC N/A
  • Revenue
  • RGNX $84,327,000.00
  • NFGC N/A
  • Revenue This Year
  • RGNX $7.91
  • NFGC N/A
  • Revenue Next Year
  • RGNX $214.75
  • NFGC N/A
  • P/E Ratio
  • RGNX N/A
  • NFGC N/A
  • Revenue Growth
  • RGNX N/A
  • NFGC N/A
  • 52 Week Low
  • RGNX $8.54
  • NFGC $1.51
  • 52 Week High
  • RGNX $28.80
  • NFGC $4.15
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 43.02
  • NFGC 25.00
  • Support Level
  • RGNX $8.87
  • NFGC $1.83
  • Resistance Level
  • RGNX $12.11
  • NFGC $1.97
  • Average True Range (ATR)
  • RGNX 0.96
  • NFGC 0.14
  • MACD
  • RGNX -0.05
  • NFGC -0.04
  • Stochastic Oscillator
  • RGNX 17.17
  • NFGC 11.29

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About NFGC New Found Gold Corp

New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).

Share on Social Networks: